HORMON PROFİLİ İLE PERİMENOPOZAL SEMPTOMLAR ARASINDAKİ İLİŞKİ

Öz

     

Anahtar Kelimeler

• Menopoz, perimenopoz, klimakterik

Kaynakça

1. Algün E. Menopoz. Turkiye Klinikleri J Endocrin 1, 2003.
2. Avis NE, Crawford S, Stellato R, Longcope C.
3. Longitudinal study of hormone levels and depression among women transitioning through menopause.
4. Climacteric 2001, 4:243-249.
5. Burger HG, Dudley E, Manners P, Groome N, Robertson DM. Early follicular phase serum FSG as a function of age: the roles of inhibin B, inhibin A and estradiol, Climacteric 3, 2000.
6. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that ocur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health, 2007, 10:247-257.
7. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause, Hum Reprod 7, 1992.
8. Fentiman IS, Allen D, Wheeler M, Rymer J. The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT. Climacteric 2006, 9:135-145.

9. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006, 63:375-382.
10. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004, 61:62-70.
11. Hunter M, Battersby R, Whitehead M. Relationships between psychological symtoms, somatic complaints and menopausal status. Maturitas 2008, 61:95-106.
12. Lasley BL, Santoro N, Randolf JF, Gold EB, Crawford S, Weiss G, McConnell DS, Sowers MF. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 87, 2002.
13. Kupesic S, Kurjak A, Bjelos D, Vujisic S. Three- dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age. Fertil Steril 79, 2003.
14. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 14, 1992.
15. Metcalf MG, Livesay JH. Gonadotropin excretion in fertile women: effect of age and the onset of the menopausel transition. J Endocrinol 105, 1985.
16. Randolph JF Jr, Sowers M, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, Brockwell SE, Matthews KA. The relationship of longitudinal change in reproductive hormones and vasomotor symtoms during the menopausal transition. J Clin Endocrinol Metab 2005, 90:6106-6112.
17. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. Seventh edition, Philadelphia, USA, Lippincott Wiliams and Wilkins, p.621-674, 2005.
18. Thurston RC, Sowers MR, Chang Y, Sternfeld B, Gold EB, Johnston JM, Matthews KA. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation. Am J Epidemol 2008, 167:78-85.
19. İstanbul Tıp Fakültesi Dergisi Cilt / Volume: 73 • Sayı / Number: 4 • Yıl/Year: 2010
20. Treloan AE, Boynton RE, Borghild GB, Brown BW. Variation of the human menstrual cycle through reproductive life, Int J Fertil 12, 1967.
21. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review. Health Qual Life Outcomes 3, 2005.
22. Vesco KK, Haney EM, Humphrey L, Fu R, Nelson HD. Influence of menopause on mood: A systematic review of cohort studies. Climacteric 2007, 10:448-465.
23. Yong PY, Baird DT, Thong KJ, McNeilly AS, Anderson RA. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down- regulation. Hum Reprod 18, 2003.